Fluoroquinolone use is the predominant risk factor for the development of a new strain of clostridium difficile-associated disease.
Patel
Nilay S
NS
Harold Hopkins Department of Urology, Royal Berkshire Hospital, Reading, UK. n1lay@doctors.net.uk
D016360:Clostridioides difficile; D003967:Diarrhea / Q000382:microbiology*; D024881:Drug Resistance, Bacterial; D004761:Enterocolitis, Pseudomembranous / Q000209:etiology*; D024841:Fluoroquinolones / Q000009:adverse effects*; D006801:Humans; D012307:Risk Factors; D014552:Urinary Tract Infections / Q000150:complications / Q000188:drug therapy*
D024841:Fluoroquinolones